Public Company News

iQIYI Celebrates Content Excellence and Social Impact at Scream Night 2024

BEIJING, Dec. 11, 2024 /PRNewswire/ -- On December 7, iQIYI, China's leading online entertainment platform, hosted its signature annual iQIYI Scream Night at the Galaxy Arena inMacao. The star-studded event unveiled a total of 66 honors across various categories, from drama to variety shows, and ...

2024-12-11 18:02 4832

Baijiayun Upgrades BRTC HarmonyOS SDK to Promote the Development of HarmonyOS Ecosystem

BEIJING, Dec. 11, 2024 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution provider, today announced it has recently upgraded the BRTC HarmonyOS SDK. As a leading domestic one-stop AI video technology service provider, Baijiayun closely ...

2024-12-11 18:00 2519

New Oriental Announces Changes in Board and Committee Composition

BEIJING, Dec. 11, 2024 /PRNewswire/ -- New Oriental Education & Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU / 9901.SEHK), a provider of private educational services inChina, today announced that Dr. John Zhuang Yang has tendered his resignation as an independent director of...

2024-12-11 17:00 2841

Weichai Energizes Global Markets through Strategic Partnerships and Innovation

WEIFANG, China, Dec. 11, 2024 /PRNewswire/ -- On December 10, the 2025 Weichai Global Partners Conference overseas session was held in Weifang,China, drawing global customers, partners and key stakeholders from theMiddle East, Africa, and Southeast Asia. The event served as a platform for reviewin...

2024-12-11 15:53 4005

A Rising Star in IC Design Services! Microip Lists on Taiwan's Emerging Stock Market on December 9. "Ultra-Fast IC Design R&D Platform" and "CUDA-like ASIC Software Platform" Empower Next-Generation Chips.

TAIPEI, Dec. 11, 2024 /PRNewswire/ -- Microip (Ticker: 7796) debuted on Taiwan's Emerging Stock Market onDecember 9 at a reference price of NT$60 per share. The stock opened atNT$74.5 and climbed to a high of NT$103, an increase of nearly 72%. With Concord Securities as the underwriter, this list...

2024-12-11 15:05 5993

Viva Biotech Officially Establishes Boston Branch, Marking Another Milestone in Global Expansion

HONG KONG, Dec. 11, 2024 /PRNewswire/ -- Recently, Viva Biotech Holdings Group ("Viva Biotech") announced the official establishment of its new branch inBoston ,USA. As a global leader in drug research, development and manufacturing services, this milestone marks a significant step forward in the ...

2024-12-11 14:44 5018

CJ 4DPLEX and EVT Expand 4DX Footprint in Australia with Three New Theaters

Castle Hill and Innaloo in Australia set to open in time for Christmas 2024 HOLLYWOOD, Calif., Dec. 11, 2024 /PRNewswire/ -- CJ 4DPLEX, the world's leading producer of premium film formats and cinema technologies, andEVT, owners of Event Cinemas, the largest movie exhibitor inAustralia and New Z...

2024-12-11 13:55 3380

Infosys Compaz Strengthens Collaboration with StarHub for Next-generation Technology Solutions

Aims to deliver advanced AI, smart city, and workplace transformation technologies for enterprise clients BENGALURU, India, Dec. 11, 2024 /PRNewswire/ -- Infosys Compaz,  a joint venture between Infosys  (NSE: INFY) (BSE: INFY) (NY...

2024-12-11 12:31 3715

AXA and HKBN Deepen Collaboration with Launch of "HKBN SmartTraveller Plus"

Providing comprehensive travel protection for worry-free travelling HONG KONG, Dec. 11, 2024 /PRNewswire/ -- AXA Hong Kong and Macau (AXA) and Hong Kong Broadband Network Limited (HKBN) have taken their collaboration another step forward by introducing"HKBN SmartTraveller Plus", a travel insuran...

2024-12-11 12:00 4463

JinkoSolar Upsizes and Extends Share Repurchase Program

SHANGRAO, China, Dec. 10, 2024 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that its board of directors ("Board") has approved the upsizing and extension of...

2024-12-11 09:41 4124

Registration Opens for NRF 2025: Retail's Big Show Asia Pacific

Early bird discounts now available for a limited time for retail's premier industry event   SINGAPORE, Dec. 11, 2024 /PRNewswire/ -- The countdown to the highly anticipatedNRF 2025: Retail's Big Show Asia Pacific (NRF 2025 APAC), organised by the National Retai...

2024-12-11 09:00 8024

SK chemicals and Hyundai Collaborate on Sustainable Automotive Development

"Recycling Technology Applied to Automobiles" * Completed the Study Car Project with Recycling Technology in Collaboration with Hyundai * Secured Technology for End-to-End Recycling, Expanding into Apparel and Electronics   Leading Chemical and Automotive Companies Join Forces to Advance the...

2024-12-11 08:00 4043

IBM Brings the Speed of Light to the Generative AI Era with Optics Breakthrough

New co-packaged optics innovation could replace electrical interconnects in data centers to offer significant improvements in speed and energy efficiency for AI and other computing applications YORKTOWN HEIGHTS, N.Y., Dec. 10, 2024 /PRNewswire/ -- IBM (NYSE: IBM ) h...

2024-12-10 23:42 3257

Live from ASH 2024 | Oral Report Features Encouraging Data of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in R/R MM, Including a Median PFS Over 9 Months

ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has released t...

2024-12-10 22:31 6054

Live from ASH 2024 | Ascentage Pharma Releases Updated Data of Bcl-2 Inhibitor Lisaftoclax in MDS that Demonstrates Potential Clinical Benefits and Favorable Safety

ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has released t...

2024-12-10 22:20 5848

Clarifai and Getty Images Announce Strategic Engagement to Make AI-Generated Images Available to Clarifai Customers

Agreement Ensures AI-Generated Images Are Responsibly Sourced, Legally Protected, and Safe for Commercial Use WASHINGTON, Dec. 10, 2024 /PRNewswire/ -- Clarifai, a global leader in AI orchestration and development and pioneer of the full-stack computer vision platform, andGetty Images (NYSE: GET...

2024-12-10 22:00 2713

DL E&C Marks First Entry into Canadian Blue Ammonia Market

* DL E&C Secures Canada Blue Ammonia Deal; CARBONCO Licenses CCUS Technology * Producing Over 1 Million Tons of Eco-Friendly Fertilizer Using Blue Ammonia and Captured CO₂ SEOUL, South Korea, Dec. 10, 2024 /PRNewswire/ -- DL Engineering & Construction (DL E&C), one ofSouth Korea's top five con...

2024-12-10 22:00 3022

Live from ASH 2024 | 1.5-Year Follow-Up Data from a Global Study of Olverembatinib Reaffirms Potential in Overcoming Resistance/Intolerance to Ponatinib or Asciminib

ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has released t...

2024-12-10 21:34 4855

Live from ASH 2024 | Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in Combinations Demonstrates Potential Clinical Benefit in Patients with Prior Exposure to Venetoclax

ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has released t...

2024-12-10 21:30 5332

Live from ASH 2024 | First Dataset of Olverembatinib as Second-Line Therapy in Patients with Non-T315I-Mutant CP-CML Presented in Oral Report

ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that Prof.Weiming Li, ...

2024-12-10 21:27 4896